Patent Assignment
Reel/Frame 031866/0539
Security Agreement
Recorded: 2013-12-20
Pages: 7
Assignor
NPS PHARMACEUTICALS, INC.
Executed: 2013-12-20
Assignee
DRUG ROYALTY L.P. 3
22 ST. CLAIR AVENUE EAST, SUITE 200, C/O DRI CAPITAL INC., TORONTO, M4T 2S5, CANADA
Covered Properties
(9)
Essentially Pure Human Parathyroid Hormone
Patent:
5,208,041 →
Application:
07/707,114 →
Parathyroid Hormone Formulation
Patent:
5,496,801 →
Application:
08/172,206 →
Methods Useful in the Treatment of Bone Resorption Diseases
Patent:
6,284,730 →
Application:
09/125,247 →
Methods Useful in the Treatment of Bone Resorption Diseases
Methods of Administering Therapeutic Injections
Methods Useful in the Treatment of Bone Resorption Diseases
Methods Useful in the Treatment of Bone Resorption Diseases
Methods Useful in the Treatment of Bone Resorption Diseases
Methods Useful in the Treatment of Bone Resorption Diseases
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 11, 2005
From: NORRIE, JAYME; HIMBERT, HANS; BENKTZON, MARIA; VEJBRINK, ULRIKA
To: NPS PHARMACEUTICALS, INC.
Reel/Frame 016443/0965 →
Articles of Arrangement
Apr 13, 2006
From: ALLELIX BIOPHARMACEUTICALS, INC.
To: NPS ALLELIX CORP.
Reel/Frame 017789/0801 →
Assignment of Assignor's Interest
Aug 7, 2008
From: NPS ALLELIX CORP.
To: NPS PHARMACEUTICALS, INC.
Reel/Frame 021339/0977 →
Assignment of Assignor's Interest
Mar 30, 2009
From: NPS ALLELIX CORP.
To: NPS PHARMACEUTICALS, INC.
Reel/Frame 022460/0626 →
Articles of Arrangement
Jul 17, 2009
From: ALLELIX BIOPHARMACEUTICALS, INC.
To: NPS ALLELIX CORP.
Reel/Frame 022973/0123 →
Assignment of Assignor's Interest
Apr 14, 2010
From: GLAXO CANADA INC.
To: ALLELIX BIOPHARMACEUTICALS INC.
Reel/Frame 024225/0989 →